You have 9 free searches left this month | for more free features.

Pazopanib in combination with interferon alpha 2A

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

Completed
  • Advanced Renal Cell Carcinoma
  • Pazopanib + interferon alpha 2A
  • Hospitalet de Llobregat, Barcelona, Spain
  • +12 more
Mar 9, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Dec 28, 2022

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

Not yet recruiting
  • Myelofibrosis
  • Pegylated interferon alpha2a
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 6, 2022

Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Miami, Florida
    Univ of Miami School of Medicine
Oct 27, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 28, 2021

Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)

Active, not recruiting
  • Chronic Hepatitis B
  • Birtinya, Queensland, Australia
  • +21 more
Dec 20, 2021

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Glioblastoma Multiforme Trial in Nice (Pazopanib)

Active, not recruiting
  • Glioblastoma Multiforme
  • Nice, Cedex 2, France
    Centre Antoine Lacassagne
Mar 3, 2022

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

HIV Trial in United States (Interferon alfa-2a, Zidovudine)

Completed
  • HIV Infections
  • Los Angeles, California
  • +5 more
Oct 26, 2021

Coronavirus Disease 2019 Trial in Santiago (Interferon-Alpha2B, Placebo)

Completed
  • Coronavirus Disease 2019
  • Santiago, RM, Chile
    Red de Salud UC Christus
Aug 3, 2022

Breast Carcinoma Trial in Houston (biological, drug, other)

Not yet recruiting
  • Breast Carcinoma
  • eftilagimod alpha
  • +2 more
  • Houston, Texas
    Oncology Consultants
Feb 17, 2023

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

Not yet recruiting
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
    Shanghai Tong Ren Hospital
Nov 12, 2021

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Recruiting
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2021

Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)

Completed
  • Diabetic Neuropathies
  • +2 more
  • Epineuron
  • Placebo group
  • Thessaloníki, Thessaloniki, Greece
    University General Hospital AHEPA
Aug 8, 2023

Sarcoma, Kaposi, HIV Trial in United States (Interferon alfa-2a, Zidovudine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Miami, Florida
  • +8 more
Oct 26, 2021